|
Back to products
Browse products
Approved anticancer agents
Anticancer agents in trials
Anticancer agents
in preclinical trials
Anticancer molecular libraries
Other drug agents
Drug intermediates
Bio-reagents and biochemicals
|
MedKoo product information:
INO-1001
|
MedKoo Code#:
201561
|
|
Name:
INO-1001
|
|
CAS#:
624747-02-0
Synonym: IN0-1001;
IUPAC/Chemical name:
3-aminobenzamide
|
|
Chemical structure: |
Theoretical analysis
|
|

|
Chemical Formula: C7H8N2O
Exact Mass: 136.06366
Molecular Weight: 136.15122
m/z: 136.06366 (100.0%), 137.06702 (7.6%)
Elemental Analysis: C, 61.75; H, 5.92; N,
20.58; O, 11.75
|
|
Availability and price:
To inquire the quotation and lead time of custom synthesis for this agent, please send email to
sales@medkoo.com to describe your needs. A representative
will respond your email shortly. We offer big discount for orders of bulk quantities.
|
|
Quality control
data:
Product will be shipped with
supporting analytical data.
|
|
Information about this agent
|
INO-1001 is an isoindolinone derivative and potent
inhibitor of the nuclear enzyme poly (ADP-ribose) polymerase (PARP) with
chemosensitization and radiosensitization properties. INO-1001 inhibits
PARP, which may result in inhibition of tumor cell DNA repair mechanisms
and, so, tumor cell resistance to chemotherapy and radiation therapy.
PARP enzymes are activated by DNA breaks and have been implicated in the
repair of DNA single-strand breaks (SSB). Check for
active clinical trials or
closed clinical trials using this agent. (NCI
Thesaurus) .
INO-1001, currently developed by Inotek
Pharmaceuticals, is known to sensitize cells to radiation in vitro
by inhibiting the repair of DNA damage. Recent evidence has suggested
that PARP inhibition may also be a way of selectively targeting p53
deficient cancer cells. The present study tested INO-1001 for its in
vivo effect on the chemoresponse of two p53 deficient tumors, human
breast cancer MDA-MB-231 and murine mammary carcinoma MCa-K.
Results showed that INO-1001 was highly effective in enhancing the
anti-tumor effects of Doxorubicin for both MDA-MB-231 (EF=1.88) and MCa-K
(EF=1.64). INO-1001 has high potential for enhancing the anti-tumor
effects of chemotherapy agents such as Doxorubicin against p53 deficient
breast cancer. For detail see:
http://www.ncbi.nlm.nih.gov/pubmed/17628743.
Current developer:
Inotek
Pharmaceuticals
1. Gartner, Elaina M.; Burger, Angelika M.; LoRusso,
Patricia M. Poly(ADP-ribose) polymerase inhibitors a novel drug class
with a promising future. Cancer Journal (Hagerstown, MD, United States)
(2010), 16(2), 83-90. CODEN: CAJOCB ISSN:1528-9117. AN 2010:600123
2. Roesner, Jan P.; Mersmann, Jan; Bergt, Stefan; Bohnenberg, Karl;
Barthuber, Carmen; Szabo, Csaba; Noeldge-Schomburg, Gabriele E. F.;
Zacharowski, Kai. Therapeutic injection of PARP inhibitor INO-1001
preserves cardiac function in porcine myocardial ischemia and
reperfusion without reducing infarct size. Shock (2010), 33(5), 507-512.
CODEN: SAGUAI ISSN:1073-2322. AN 2010:486940
3. Maier, Christian Frank. Effects of the PARP-1 of inhibitor INO-1001
on ischemia reperfusion-associated organ damages after thoracic aortal
cross-clamping on the pig. (2009), No pp. AN 2010:483793
4. Wang, Yaolin; Wang, Yan; Liu, Ming; Bishop, Walter Robert;
Seidel-Dugan, Cynthia. Anti-IGF-1 receptor antibody combined with
chemotherapeutic agent, antitumor agent, radiotherapy or surgery for
treating or preventing colorectal cancer. PCT Int. Appl. (2009), 52pp.
CODEN: PIXXD2 WO 2009142810 A2 20091126 CAN 151:569615 AN 2009:1470605
5. Wang, Yaolin; Wang, Yan; Lu, Brian Der-Hua; Liu, Ming; Seidel-Dugan,
Cynthia; Yao, Siu-Long. Sequential administration of chemotherapeutic
agents and anti-(insulin-like growth factor 1 receptor) for treatment of
cancer. PCT Int. Appl. (2009), 104 pp. CODEN: PIXXD2 WO 2009137378 A2
20091112 CAN 151:521177 AN 2009:1395230
6. Boulares, Hamid A.; Hans, Chetan P.; Naura, Amarjit S. Regression of
established atherosclerotic plaques, and treating sudden-onset asthma
attacks, using PARP inhibitors. PCT Int. Appl. (2009), 27 pp. CODEN:
PIXXD2 WO 2009126606 A2 20091015 CAN 151:440670 AN 2009:1262359
7. Mann, David Marshall. Gene expression profiling in the pulmonary
artery in the selection of therapies for vascular-related diseases. PCT
Int. Appl. (2009), 115pp. CODEN: PIXXD2 WO 2009121031 A1 20091001 CAN
151:418165 AN 2009:1194632
8. O'Malley, Bert W.; Abuzeid, Waleed M.; Li, Daqing. Anti-neoplastic
combination therapeutic regimen involving co-disruption of PARP pathway
and Mre11/Rad50/Nbs1 complex and compositons useful therein. PCT Int.
Appl. (2009), 39 pp. CODEN: PIXXD2 WO 2009114459 A2 20090917 CAN
151:366712 AN 2009:1141539
9. Bedikian, Agop Y.; Papadopoulos, Nicholas E.; Kim, Kevin B.; Hwu, Wen-Jen;
Homsi, Jade; Glass, Michelle R.; Cain, Suzanne; Rudewicz, Patrick;
Vernillet, Laurent; Hwu, Patrick. A Phase IB Trial of Intravenous
INO-1001 Plus Oral Temozolomide in Subjects with Unresectable Stage-III
or IV Melanoma. Cancer Investigation (2009), 27(7), 756-763. CODEN:
CINVD7 ISSN:0735-7907. CAN 152:303598 AN 2009:926179
10. Fink, Mitchell P. A method using a peroxynitrite decomposition agent
or other agent for prevention of contrast-induced nephropathy. PCT Int.
Appl. (2009), 99 pp. CODEN: PIXXD2 WO 2009088860 A2 20090716 CAN
151:164326 AN 2009:858783
11. Wang, Yan; Wang, Yaolin; Levitan, Diane; Seidel-Dugan, Cynthia; Liu,
Ming; Ding, Wei. Gene expression biomarkers for detecting IGF1R
inhibitor-resistant or -sensitive cancers and uses in anti-IGF1R
antibody combination chemotherapy. PCT Int. Appl. (2009), 165pp. CODEN:
PIXXD2 WO 2009079587 A2 20090625 CAN 151:116583 AN 2009:769153
12. Morrow, David A.; Brickman, Chaim M.; Murphy, Sabina A.; Baran,
Kenneth; Krakover, Ricardo; Dauerman, Harold; Kumar, Sujatha; Slomowitz,
Natanya; Grip, Laura; McCabe, Carolyn H.; Salzman, Andrew L. A
randomized, placebo-controlled trial to evaluate the tolerability,
safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of
poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation
myocardial infarction undergoing primary percutaneous coronary
intervention: results of the TIMI 37 trial. Journal of Thrombosis and
Thrombolysis (2009), 27(4), 359-364. CODEN: JTTHFF ISSN:0929-5305. CAN
151:542837 AN 2009:574115
13. Ramachandra, Sumant; Bishop, Robert Walter; Masat, Linda; Huang,
Chao Bai; Takeuchi, Toshihiko; Kantak, Seema. Human anti-VEGF antibodies
and conjugates for treatment of angiogenesis conditions. PCT Int. Appl.
(2009), 195pp. CODEN: PIXXD2 WO 2009055343 A2 20090430 CAN 150:492909 AN
2009:519479
14. Wang, Yan; Pachter, Jonathan A.; Hailey, Judith Anne; Brams, Peter;
Williams, Denise; Srinivasan, Mohan; Feingersh, Mary Diane.
Anti-insulin-like growth factor 1 receptor therapy. PCT Int. Appl.
(2009), 129pp. CODEN: PIXXD2 WO 2009005673 A1 20090108 CAN 150:119716 AN
2009:25215
15. Dhein, S.; Krause, N.; Ullmann, C.; Flister, A.; Lehmann, S.; Muth,
P.; Walther, T.; Kostelka, M.; Mohr, F. W. Ischemic and inflammatory
lung impairment by extracorporeal circulation: Effect of PARP-inhibition
by INO1001. Pharmacological Research (2008), 58(5-6), 332-339. CODEN:
PHMREP ISSN:1043-6618. CAN 150:530685 AN 2008:1442900
16. Maier, Christian; Scheuerle, Angelika; Hauser, Balazs; Schelzig,
Hubert; Szabo, Csaba; Radermacher, Peter; Kick, Jochen. The selective
poly(ADP)ribose-polymerase 1 inhibitor INO1001 reduces spinal cord
injury during porcine aortic cross-clamping-induced ischemia/reperfusion
injury. Intensive Care Medicine (2007), 33(5), 845-850. CODEN: ICMED9
ISSN:0342-4642. CAN 150:159887 AN 2008:1096402
17. Wang, Yan; Zong, Chen; Seidel-Dugan, Cynthia; Wang, Yaolin; Yao, Siu-Long;
Lu, Brian Der-Hua; Ladha, Mohamed H. Methods of treating cancer using
IGF1R inhibitors. PCT Int. Appl. (2008), 103pp. CODEN: PIXXD2 WO
2008076278 A2 20080626 CAN 149:102715 AN 2008:771165
18. Biro, Alexander; Katzir, Ze'ev. Combination of an aminoglycoside
antibiotic and a poly(ADP-ribose) polymerase (PARP) inhibitor for the
treatment of aminoglycoside antibiotic-associated nephrotoxicity. PCT
Int. Appl. (2008), 43pp. CODEN: PIXXD2 WO 2008050339 A2 20080502 CAN
148:509922 AN 2008:529810
19. McCourtie, Anton S.; Farivar, Alexander S.; Woolley, Steven M.;
Merry, Heather E.; Wolf, Patrick S.; Szabo, Csaba; Mulligan, Michael S.
Poly (ADP) ribose synthetase inhibition in alveolar macrophages
undergoing hypoxia and reoxygenation. Experimental and Molecular
Pathology (2008), 84(2), 141-144. CODEN: EXMPA6 ISSN:0014-4800. CAN
149:6514 AN 2008:406563
20. Ashworth, Alan; Lord, Christopher James; Turner, Nicholas Charles.
Methods of increasing the sensitivity of cancer cells to DNA damage. PCT
Int. Appl. (2008), 96 pp. CODEN: PIXXD2 WO 2008020180 A2 20080221 CAN
148:276718 AN 2008:223698
21. Mason, Kathryn A.; Valdecanas, David; Hunter, Nancy R.; Milas, Luka.
INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase, enhances
tumor response to doxorubicin. Investigational New Drugs (2008), 26(1),
1-5. CODEN: INNDDK ISSN:0167-6997. CAN 148:486493 AN 2008:52293
22. Wang, Yan. Blood levels of insulin-like growth factor-binding
protein 2 as a marker for monitoring the effectiveness of inhibitors of
insulin-like growth factor I receptors in cancer therapy. PCT Int. Appl.
(2008), 133pp. CODEN: PIXXD2 WO 2008005469 A2 20080110 CAN 148:135980 AN
2008:43490
23. Radovits, Tamas; Zotkina, Julia; Lin, Li-ni; Boemicke, Timo; Arif,
Rawa; Gero, Domokos; Horvath, Eszter M.; Karck, Matthias; Szabo, Csaba;
Szabo, Gabor. Poly(ADP-ribose) polymerase inhibition improves
endothelial dysfunction induced by hypochlorite. Experimental Biology
and Medicine (Maywood, NJ, United States) (2007), 232(9), 1204-1212.
CODEN: EBMMBE ISSN:1535-3702. CAN 147:439969 AN 2007:1164877
24. Scotto, Kathleen A.; Mandola, Michael. Use of PARP-1 inhibitors for
improvement of the cytotoxic effect of ecteinascidin-743 in the
treatment of cancer. PCT Int. Appl. (2007), 16 pp. CODEN: PIXXD2 WO
2007062413 A2 20070531 CAN 147:2005 AN 2007:591050
25. Radovits, Tamas; Seres, Leila; Gero, Domokos; Berger, Irina; Szabo,
Csaba; Karck, Matthias; Szabo, Gabor. Single dose treatment with
PARP-inhibitor INO-1001 improves aging-associated cardiac and vascular
dysfunction. Experimental Gerontology (2007), 42(7), 676-685. CODEN:
EXGEAB ISSN:0531-5565. CAN 147:314621 AN 2007:559263
26. Radovits, Tamas; Lin, Li-ni; Zotkina, Julia; Gero, Domokos; Szabo,
Csaba; Karck, Matthias; Szabo, Gabor. Poly(ADP-ribose) polymerase
inhibition improves endothelial dysfunction induced by reactive oxidant
hydrogen peroxide in vitro. European Journal of Pharmacology (2007),
564(1-3), 158-166. CODEN: EJPHAZ ISSN:0014-2999. CAN 147:133628 AN
2007:524150
27. Yasuhiro, Tetsuya; Kitajima, Takashi; Wakamatsu, Daisuke; Kamoshima,
Wataru. Agent for reduction of bleeding in cerebrovascular disorder. PCT
Int. Appl. (2006), 44pp. CODEN: PIXXD2 WO 2006137510 A1 20061228 CAN
146:93553 AN 2006:1357083
28. Szabo, Csaba; Biser, Alisha; Benko, Rita; Bottinger, Erwin; Susztak,
Katalin. Poly(ADP-ribose) polymerase inhibitors ameliorate nephropathy
of type 2 diabetic Leprdb/db mice. Diabetes (2006), 55(11), 3004-3012.
CODEN: DIAEAZ ISSN:0012-1797. CAN 146:114727 AN 2006:1198396
29. Beller, Carsten J.; Kosse, Jens; Radovits, Tamas; Geroe, Domokos;
Krempien, Robert; Gross, Marie-Luise; Berger, Irina; Hagl, Siegfried;
Szabo, Csaba; Szabo, Gabor. Poly(ADP-ribose) polymerase inhibition
combined with irradiation: a dual treatment concept to prevent
neointimal hyperplasia after endarterectomy. International Journal of
Radiation Oncology, Biology, Physics (2006), 66(3), 867-875. CODEN:
IOBPD3 ISSN:0360-3016. CAN 146:513885 AN 2006:1023433
30. Beller, Carsten J.; Radovits, Tamas; Seres, Leila; Kosse, Jens;
Krempien, Robert; Gross, Marie-Luise; Penzel, Roland; Berger, Irina;
Huber, Peter E.; Hagl, Siegfried; Szabo, Csaba; Szabo, Gabor.
Poly(ADP-ribose) polymerase inhibition reverses vascular dysfunction
after -irradiation. International Journal of Radiation Oncology,
Biology, Physics (2006), 65(5), 1528-1535. CODEN: IOBPD3 ISSN:0360-3016.
CAN 146:220587 AN 2006:739116
31. Szabo, Gabor; Baehrle, Susanne; Stumpf, Nicole; Szabo, Csaba; Hagl,
Siegfried. Contractile dysfunction in experimental cardiac allograft
rejection: role of the poly (ADP-ribose) polymerase pathway. Transplant
International (2006), 19(6), 506-513. CODEN: TRINE5 ISSN:0934-0874. CAN
145:483451 AN 2006:659829
32. Hauser, Balazs; Groeger, Michael; Ehrmann, Ulrich; Albicini, Maura;
Brueckner, Uwe Bernd; Schelzig, Hubert; Venkatesh, Balasubramanian; Li,
Hongshan; Szabo, Csaba; Speit, Guenter; Radermacher, Peter; Kick, Jochen.
The PARP-1 inhibitor INO-1001 facilitates hemodynamic stabilization
without affecting DNA repair in porcine thoracic aortic
cross-clamping-induced ischemia/reperfusion. Shock (2006), 25(6),
633-640. CODEN: SAGUAI ISSN:1073-2322. CAN 145:431947 AN 2006:583501
33. Toth, Orsolya; Szabo, Csaba; Kecskes, Marianna; Poto, Laszlo; Nagy,
Agnes; Losonczy, Hajna. In vitro effect of the potent poly(ADP-ribose)
polymerase (PARP) inhibitor INO-1001 alone and in combination with
aspirin, eptifibatide, tirofiban, enoxaparin, or alteplase on
haemostatic parameters. Life Sciences (2006), 79(4), 317-323. CODEN:
LIFSAK ISSN:0024-3205. CAN 145:201990 AN 2006:536823
34. Hellstrand, Kristoffer; Hermodsson, Svante; Thoren, Fredrik; Romero,
Ana. Use of parp-1 inhibitors for protecting tumorcidal lymphocytes from
apoptosis. PCT Int. Appl. (2006), 42 pp. CODEN: PIXXD2 WO 2006039545 A2
20060413 CAN 144:363088 AN 2006:343963
35. Wang, Xi; Satoh, Hiroko; Kase, Hiroyuki; Suzuki, Kunihiro; Iwata,
Chigusa; Hattori, Yoshiyuki; Kasai, Kikuo. Effect of poly(ADP-ribose)
polymerase inhibitors on hypoadiponectinemia caused by chronic blockade
of nitric oxide synthesis in rats. Dokkyo Journal of Medical Sciences
(2005), 32(2), 85-89. CODEN: DJMSDB ISSN:0385-5023. CAN 145:202427 AN
2006:281206
36. Ye, Diana Z.; Tai, Mei-Hui; Linning, Katrina D.; Szabo, Csaba;
Olson, L. Karl. MafA expression and insulin promoter activity are
induced by nicotinamide and related compounds in INS-1 pancreatic
-cells. Diabetes (2006), 55(3), 742-750. CODEN: DIAEAZ ISSN:0012-1797.
CAN 144:381740 AN 2006:241121
37. Pacher, Pal; Liaudet, Lucas; Mabley, Jon G.; Cziraki, Attila; Hasko,
Gyorgy; Szabo, Csaba. Beneficial effects of a novel ultrapotent
poly(ADP-ribose) polymerase inhibitor in murine models of heart failure.
International Journal of Molecular Medicine (2006), 17(2), 369-375.
CODEN: IJMMFG ISSN:1107-3756. CAN 145:95893 AN 2006:143526
38. Kendirci, Muammer; Zsengeller, Zsuzsanna; Bivalacqua, Trinity J.;
Gur, Serap; Usta, Mustafa F.; Chen, Min; Szabo, Csaba; Hellstrom, Wayne
J. G. Poly(Adenosine Diphosphate-Ribose) Polymerase Inhibition Preserves
Erectile Function in Rats After Cavernous Nerve Injury. Journal of
Urology (Hagerstown, MD, United States) (2005), 174(5), 2054-2059.
CODEN: JOURAA ISSN:0022-5347. CAN 144:184446 AN 2005:1098566
39. Cheng, C. Lynn; Johnson, Stewart P.; Keir, Stephen T.; Quinn,
Jennifer A.; Ali-Osman, Francis; Szabo, Csaba; Li, Hongshan; Salzman,
Andrew L.; Dolan, M. Eileen; Modrich, Paul; Bigner, Darell D.; Friedman,
Henry S. Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide
resistance in a DNA mismatch repair-deficient malignant glioma xenograft.
Molecular Cancer Therapeutics (2005), 4(9), 1364-1368. CODEN: MCTOCF
ISSN:1535-7163. CAN 143:318623 AN 2005:1064573
40. Brownlee, Michael A. Glp-1 (9-36) methods and compositions. PCT Int.
Appl. (2005), 28 pp. CODEN: PIXXD2 WO 2005060986 A1 20050707 CAN
143:91055 AN 2005:588685
41. Brownlee, Michael. Use of poly(ADP-ribose) polymerase inhibitors for
prevention and treatment of diabetic and insulin resistance
complications. PCT Int. Appl. (2005), 52 pp. CODEN: PIXXD2 WO 2005037990
A2 20050428 CAN 142:428133 AN 2005:371374
42. Besson, Valerie C.; Zsengeller, Zsuzsanna; Plotkine, Michel; Szabo,
Csaba; Marchand-Verrecchia, Catherine. Beneficial effects of PJ34 and
INO-1001, two novel water-soluble poly(ADP-ribose) polymerase
inhibitors, on the consequences of traumatic brain injury in rat. Brain
Research (2005), 1041(2), 149-156. CODEN: BRREAP ISSN:0006-8993. CAN
142:441744 AN 2005:319312
43. Xiao, Chun-Yang; Chen, Min; Zsengeller, Zsuzsanna; Li, Hongshan;
Kiss, Levente; Kollai, Mark; Szabo, Csaba. Poly(ADP-ribose) polymerase
promotes cardiac remodeling, contractile failure, and translocation of
apoptosis-inducing factor in a murine experimental model of aortic
banding and heart failure. Journal of Pharmacology and Experimental
Therapeutics (2005), 312(3), 891-898. CODEN: JPETAB ISSN:0022-3565. CAN
142:237688 AN 2005:207276
44. Szabo, Gabor; Soos, Pal; Mandera, Susanne; Heger, Ulrike;
Flechtenmacher, Christa; Seres, Leila; Zsengeller, Zsuzsanna; Sack,
Falk-Udo; Szabo, Csaba; Hagl, Siegfried. Mesenteric injury after
cardiopulmonary bypass: Role of poly(adenosine 5'-diphosphate-ribose)
polymerase. Critical Care Medicine (2004), 32(12), 2392-2397. CODEN:
CCMDC7 ISSN:0090-3493. CAN 142:290973 AN 2004:1079106
45. Szabo, Csaba; Pacher, Pal; Zsengeller, Zsuzsanna; Vaslin, Anne;
Komjati, Katalin; Benko, Rita; Chen, Min; Mabley, Jon G.; Kollai, Mark.
Angiotensin II-mediated endothelial dysfunction: role of
poly(ADP-ribose) polymerase activation. Molecular Medicine (Manhasset,
NY, United States) (2004), 10(1-6), 28-35. CODEN: MOMEF3 ISSN:1076-1551.
CAN 142:53712 AN 2004:1039127
46. Pacher, Pal; Vaslin, Anne; Benko, Rita; Mabley, Jon G.; Liaudet,
Lucas; Hasko, Gyoergy; Marton, Anita; Batkai, Sandor; Kollai, Mark;
Szabo, Csaba. A new, potent poly(ADP-ribose) polymerase inhibitor
improves cardiac and vascular dysfunction associated with advanced
aging. Journal of Pharmacology and Experimental Therapeutics (2004),
311(2), 485-491. CODEN: JPETAB ISSN:0022-3565. CAN 141:360429 AN
2004:906862
47. Xiao, Chun-Yang; Chen, Min; Zsengeller, Zsuzsanna; Szabo, Csaba.
Poly(ADP-ribose) polymerase contributes to the development of myocardial
infarction in diabetic rats and regulates the nuclear translocation of
apoptosis-inducing factor. Journal of Pharmacology and Experimental
Therapeutics (2004), 310(2), 498-504. CODEN: JPETAB ISSN:0022-3565. CAN
141:138311 AN 2004:608715
48. Benko, Rita; Pacher, Pal; Vaslin, Anne; Kollai, Mark; Szabo, Csaba.
Restoration of the endothelial function in the aortic rings of
apolipoprotein E deficient mice by pharmacological inhibition of the
nuclear enzyme poly(ADP-ribose) polymerase. Life Sciences (2004),
75(10), 1255-1261. CODEN: LIFSAK ISSN:0024-3205. CAN 141:171979 AN
2004:519866
49. Szabo, Gabor; Soos, Pal; Mandera, Susanne; Heger, Ulrike;
Flechtenmacher, Christa; Baehrle, Susanne; Seres, Leila; Cziraki,
Attila; Gries, Andre; Zsengeller, Zsuszanna; Vahl, Christian F.; Hagl,
Siegfried; Szabo, Csaba. INO-1001 a novel poly(ADP-ribose) polymerase
(PARP) inhibitor improves cardiac and pulmonary function after
crystalloid cardioplegia and extracorporal circulation. Shock (2004),
21(5), 426-432. CODEN: SAGUAI ISSN:1073-2322. CAN 141:388392 AN
2004:420231
50. Murakami, Kazunori; Enkhbaatar, Perenlei; Shimoda, Katsumi; Cox,
Robert A.; Burke, Ann S.; Hawkins, Hal K.; Traber, Lillian D.;
Schmalstieg, Frank C.; Salzman, Andrew L.; Mabley, Jon G.; Komjati,
Katalin; Pacher, Pal; Zzengeller, Zsuzsanna; Szabo, Csaba; Traber,
Daniel L. Inhibition of poly(ADP-ribose) polymerase attenuates acute
lung injury in an ovine model of sepsis. Shock (2004), 21(2), 126-133.
CODEN: SAGUAI ISSN:1073-2322. CAN 140:421712 AN 2004:301889
|
Contact MedKoo:
Email:
sales@medkoo.com
(Keyword; CAS#; MedKoo code#)
|